| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 767 | 2015 |
| Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients RA Asherson, R Cervera, JC Piette, Y Shoenfeld, G Espinosa, MA Petri, ... Medicine 80 (6), 355-377, 2001 | 496 | 2001 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 470 | 2021 |
| Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients R Cervera, MA Khamashta, Y Shoenfeld, MT Camps, S Jacobsen, E Kiss, ... Annals of the Rheumatic Diseases 68 (9), 1428-1432, 2009 | 393 | 2009 |
| Mortality in the catastrophic antiphospholipid syndrome: causes of death and prognostic factors in a series of 250 patients S Bucciarelli, G Espinosa, R Cervera, D Erkan, JA Gómez‐Puerta, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2006 | 363 | 2006 |
| Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults J Font, R Cervera, G Espinosa, L Pallarés, M Ramos-Casals, S Jiménez, ... Annals of the Rheumatic Diseases 57 (8), 456-459, 1998 | 347 | 1998 |
| Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome R Cervera, J Font, JA Gómez-Puerta, G Espinosa, M Cucho, S Bucciarelli, ... Annals of the rheumatic diseases 64 (8), 1205-1209, 2005 | 318 | 2005 |
| Treatment of antineutrophil cytoplasmic antibody–associated vasculitis: a systematic review X Bosch, A Guilabert, G Espinosa, E Mirapeix Jama 298 (6), 655-669, 2007 | 291 | 2007 |
| Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry I Rodríguez-Pintó, M Moitinho, I Santacreu, Y Shoenfeld, D Erkan, ... Autoimmunity Reviews 15 (12), 1120-1124, 2016 | 263 | 2016 |
| Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients R Cervera, RA Asherson, ML Acevedo, JA Gómez-Puerta, G Espinosa, ... Annals of the rheumatic diseases 63 (10), 1312-1317, 2004 | 253 | 2004 |
| Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis MD Mayes, L Bossini-Castillo, O Gorlova, JE Martin, X Zhou, WV Chen, ... The American Journal of Human Genetics 94 (1), 47-61, 2014 | 249 | 2014 |
| Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab H Berman, I Rodríguez-Pintó, R Cervera, N Morel, ... Autoimmunity Reviews 12 (11), 1085-1090, 2013 | 244 | 2013 |
| Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients G Espinosa, E Santos, R Cervera, JC Piette, G de la Red, V Gil, J Font, ... Medicine 82 (2), 106-118, 2003 | 240 | 2003 |
| Failure of intravenous immunoglobulin to prevent congenital heart block: findings of a multicenter, prospective, observational study CN Pisoni, A Brucato, A Ruffatti, G Espinosa, R Cervera, ... Arthritis & Rheumatism 62 (4), 1147-1152, 2010 | 231 | 2010 |
| Analysis of patient flow in the emergency department and the effect of an extensive reorganisation O Miro, M Sanchez, G Espinosa, B Coll-Vinent, E Bragulat, J Milla Emergency Medicine Journal 20 (2), 143-148, 2003 | 226 | 2003 |
| Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double‐blind, placebo‐controlled trials MEB Clowse, DJ Wallace, RA Furie, MA Petri, MC Pike, P Leszczyński, ... Arthritis & rheumatology 69 (2), 362-375, 2017 | 224 | 2017 |
| Etiopathogenesis of Behcet's disease C Mendoza-Pinto, M García-Carrasco, M Jiménez-Hernández, ... Autoimmunity reviews 9 (4), 241-245, 2010 | 224 | 2010 |
| Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies G Espinosa, S Bucciarelli, R Cervera, M Lozano, JC Reverter, ... Annals of the rheumatic diseases 63 (6), 730-736, 2004 | 223 | 2004 |
| Vascular involvement in Behçet’s disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin G Espinosa, J Font, D Tàssies, A Vidaller, R Deulofeu, A López-Soto, ... The American journal of medicine 112 (1), 37-43, 2002 | 219 | 2002 |
| Catastrophic antiphospholipid syndrome: updated diagnostic algorithms D Erkan, G Espinosa, R Cervera Autoimmunity reviews 10 (2), 74-79, 2010 | 216 | 2010 |
